Equities

Invent Medic Sweden AB

IMS:AKT

Invent Medic Sweden AB

Actions
  • Price (SEK)0.65
  • Today's Change0.00 / 0.00%
  • Shares traded1.67k
  • 1 Year change-31.29%
  • Beta--
Data delayed at least 15 minutes, as of May 08 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Invent Medic Sweden AB is a Sweden-based company, which is primarily engaged in the healthcare industry. The Company manufactures TVS that is a medical device for non-surgical treatment of female stress urinary incontinence. The product has a similar mechanism of action as the surgical treatment method. Effect time-mechanism is based on two parts with the upper annular support incontinence in the upper part of the urethra while the lower part comprises an external fixation plate that ensures that the TVS placed correctly. Following the introduction of the product is the labia range around the reference part to ensure that the supporting part is always positioned correctly in order to exert its effect.

  • Revenue in SEK (TTM)6.71m
  • Net income in SEK-8.53m
  • Incorporated2005
  • Employees8.00
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Perpetua Medical AB (publ)9.94m-18.28m10.16m----0.7683--1.02-0.5927-0.59270.23220.12180.63786.603.78---117.31-83.52-164.97-102.1958.8563.46-183.94-250.302.14--0.0068---1.7657.204.63--8.89--
Qlife Holding AB244.00k-159.96m10.98m--------45.01-0.2636-0.26360.0003-0.02230.00211.540.2847---138.07---256.73---4,761.48---65,556.15--0.1683-19.45-----98.64---71.74------
S2Medical AB (publ)6.97m-22.71m11.49m----7.81--1.65-0.109-0.1090.04210.0060.29850.33485.24---97.24-65.16-520.37-101.5072.2665.03-325.74-220.190.1754-2.050.00--49.2736.0522.91---14.79--
Medfield Diagnostics AB713.00k-15.02m18.01m----0.2442--25.26-0.2513-0.25130.0120.92980.0093-1.880.5942---19.55-14.34-20.52-15.38765.78547.85-2,106.17-826.132.61-12.28-----70.29---79.42--3.75--
Medimi AB3.64m-14.25m22.65m6.00--1.59--6.23-0.0213-0.02130.00520.01320.18760.62284.68606,148.30-73.50-81.87-87.84-93.9356.054.06-391.85-840.934.14-134.590.1791--75.13280.697.52------
Invent Medic Sweden AB6.71m-8.53m26.11m8.00--5.08--3.89-0.2275-0.22750.17870.12810.68072.124.10838,421.30-86.60-97.56-123.70-121.0677.7677.16-127.22-490.981.05-21.440.3058--115.97177.5328.77---22.61--
ATTANA AB5.05m-13.83m31.04m----1.18--6.14-0.0468-0.04680.01690.06760.1626-0.54782.30---44.53-37.21-70.65-46.79134.99175.97-273.78-254.870.6238-8.710.1445---32.896.615.50--7.55--
Chordate Medical Holding AB (publ)976.29k-29.19m31.34m3.00--1.30--32.10-0.0955-0.09550.00320.04930.0481-0.21238.42325,430.00-143.79-91.98-223.15-122.85134.10209.52-2,989.55-3,295.751.60--0.00--799.630.6511-4.45------
Neodynamics AB (publ)321.00k-92.67m32.55m----0.1759--101.39-39.35-39.350.10235.670.00417.610.0245---117.68-53.18-146.30-61.85-13,815.58---28,867.60-17,683.520.6984-25.64----137.95---24.36---45.17--
Scandinavian ChemoTech AB2.82m-21.09m39.09m6.00--3.90--13.85-1.58-1.580.20940.6150.15430.32655.75470,333.30-115.35-87.29-168.57-118.5558.75252.05-747.38-2,122.770.8244-23.700.00--496.6219.137.28------
Data as of May 08 2024. Currency figures normalised to Invent Medic Sweden AB's reporting currency: Swedish Krona SEK
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.